Division of Hematology and Oncology Archives
Kidney cancer patient, survivor event set for Sept. 9
Aug. 17, 2017—Vanderbilt-Ingram Cancer Center (VICC) will sponsor an educational conference for kidney cancer patients, survivors and family members Saturday, Sept. 9, 8 a.m. – 2 p.m., in the Preston Research Building, Suite 898.
Vanderbilt’s W. Kimryn Rathmell named to ASCI leadership post
Apr. 20, 2017—W. Kimryn Rathmell, director of the Division of Hematology/Oncology at Vanderbilt University Medical Center, has been named vice president of The American Society for Clinical Investigation.
Endowed fellowships help create personal connections
May. 12, 2016—When former Nashvillian Carol O’Hare speaks about a specific group of physicians at Vanderbilt-Ingram Cancer Center (VICC), her voice softens, and she refers to them affectionately as “my fellows.”
Rathmell to direct Division of Hematology and Oncology
Aug. 13, 2015—W. Kimryn Rathmell, M.D., Ph.D., Alexander Professor for Translational Science and associate director for Training and Education at Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, has been named director of Vanderbilt’s Division of Hematology and Oncology.
Kitko to lead Pediatric Stem Cell Transplant Program
Jul. 16, 2015—Carrie Kitko, M.D., has joined Monroe Carell Jr. Children’s Hospital at Vanderbilt as associate professor of Pediatrics and director of the Pediatric Stem Cell Transplant Program in the Division of Hematology/Oncology.
Hhex on cancer
Jul. 13, 2015—A new mouse model demonstrates that the Hhex gene – which is linked to blood cancers – is critical for normal blood cell production.
Probing the pathogenesis of leukemia
Feb. 27, 2014—A new mouse model reveals gene clusters important in a treatment-resistant form of leukemia.
Kudos: Read about faculty and staff awards and achievements
Jan. 10, 2014—Read about faculty and staff awards and achievements in the latest edition of "Kudos."
Probing mutant EGF receptor regulation
Oct. 10, 2013—Understanding the regulation of mutant EGF receptors commonly found in lung cancers could lead to new targeted therapies.
Leukemia culprit’s cellular actions
Apr. 11, 2013—Overexpression of a gene that is a common culprit in leukemia induces stem cell-like features in T cells, which may enable the cells to become cancerous.
Foundation lauds graduate student’s melanoma research
Mar. 28, 2013—Katherine Hutchinson, a third-year graduate student in Cancer Biology at Vanderbilt University, has won a $10,000 Research Scholar Award from the Joanna M. Nicolay Melanoma Foundation.
